← Back to guidelines
Dermatology17 papers

Tufted folliculitis

Last edited: 4/14/2026

Overview

Tufted folliculitis, often caused by Malassezia yeasts, presents as pruritic papules, frequently misdiagnosed as acne vulgaris. Characterized by yeast-like fungi in hair follicles, it commonly affects areas like the chest and trunk 123.

Diagnosis

  • Clinical Features: Characteristic papules, often in clusters, typically on the chest, trunk, and face 13.
  • Microscopic Examination: Direct microscopy showing ≥10 yeast-like fungi per follicle; KOH/Parker blue ink mounts are useful 12.
  • Histology: Routine histology with hematoxylin and eosin staining; Periodic acid-Schiff staining can confirm Malassezia presence 2.
  • Management

  • First-Line Treatments:
  • - Topical Antifungals: 2% ketoconazole cream 1. - Systemic Antifungals: Oral itraconazole 100 mg/day or ketoconazole 200 mg/day 12.
  • Adjunctive Treatments:
  • - Ketoconazole Shampoo: Twice weekly maintenance after initial treatment 2. - Antimycotics with Acne Treatment: For coexisting acne vulgaris, adding antimycotics to acne regimen can be effective 3.

    Special Populations

  • Coexisting Conditions: Management of coexisting acne vulgaris with antimycotic therapy shows significant improvement 3.
  • No Specific Guidance: Limited data on pregnancy, pediatrics, or elderly populations 123.
  • Key Recommendations

  • Diagnose via Direct Microscopy: Confirm Malassezia folliculitis using direct microscopy showing ≥10 yeast-like fungi per follicle (Evidence: Moderate 12).
  • Initiate with Topical Ketoconazole: For mild to moderate cases, start with 2% ketoconazole cream (Evidence: Moderate 1).
  • Consider Systemic Therapy for Rapid Response: For severe or refractory cases, oral itraconazole or ketoconazole can provide quicker resolution (Evidence: Moderate 12).
  • Maintain with Ketoconazole Shampoo: Post-treatment, use ketoconazole shampoo twice weekly to prevent recurrence (Evidence: Moderate 2).
  • Combine with Acne Therapy if Coexisting: In cases with acne vulgaris, incorporating antimycotic therapy into acne treatment regimen can be highly effective (Evidence: Moderate 3).
  • References

    1 Suzuki C, Hase M, Shimoyama H, Sei Y. Treatment Outcomes for Malassezia Folliculitis in theDermatology Department of a University Hospital in Japan. Medical mycology journal 2016. link 2 Abdel-Razek M, Fadaly G, Abdel-Raheim M, al-Morsy F. Pityrosporum (Malassezia) folliculitis in Saudi Arabia--diagnosis and therapeutic trials. Clinical and experimental dermatology 1995. link 3 Jacinto-Jamora S, Tamesis J, Katigbak ML. Pityrosporum folliculitis in the Philippines: diagnosis, prevalence, and management. Journal of the American Academy of Dermatology 1991. link70104-a) 4 Scott MJ, Scott MJ, Scott AM. Epilation. Cutis 1990. link 5 Golitz L. Follicular and perforating disorders. Journal of cutaneous pathology 1985. link 6 James WD, Leyden JJ. Treatment of gram-negative folliculitis with isotretinoin: positive clinical and microbiologic response. Journal of the American Academy of Dermatology 1985. link80043-8)

    Original source

    1. [1]
    2. [2]
      Pityrosporum (Malassezia) folliculitis in Saudi Arabia--diagnosis and therapeutic trials.Abdel-Razek M, Fadaly G, Abdel-Raheim M, al-Morsy F Clinical and experimental dermatology (1995)
    3. [3]
      Pityrosporum folliculitis in the Philippines: diagnosis, prevalence, and management.Jacinto-Jamora S, Tamesis J, Katigbak ML Journal of the American Academy of Dermatology (1991)
    4. [4]
      Epilation.Scott MJ, Scott MJ, Scott AM Cutis (1990)
    5. [5]
      Follicular and perforating disorders.Golitz L Journal of cutaneous pathology (1985)
    6. [6]
      Treatment of gram-negative folliculitis with isotretinoin: positive clinical and microbiologic response.James WD, Leyden JJ Journal of the American Academy of Dermatology (1985)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG